Search for: "Teva Pharmaceuticals"
Results 721 - 740
of 1,426
Sorted by Relevance
|
Sort by Date
4 Dec 2018, 2:51 pm
Teva Pharmaceuticals USA, Inc., No. 17-1229. [read post]
2 Dec 2018, 9:00 am
Teva Pharmaceuticals USA Inc. [read post]
11 Oct 2011, 2:19 pm
Teva Pharmaceuticals, who agreed to purchase Cephalon for $6.8 billion, did not express concern. [read post]
23 Jan 2019, 12:24 pm
Teva Pharmaceuticals wanted to market a generic palonosetron product in 2011. [read post]
13 May 2019, 1:45 pm
Enlarge / A Teva facility in France. [read post]
9 Apr 2010, 8:30 am
Both products are manufactured by TEVA Pharmaceuticals USA in North Wales, Pa. [read post]
3 Aug 2009, 7:29 am
.; Barr Pharmaceuticals, Inc.; Baxter Healthcare Corp.; Duramed Pharmaceuticals, Inc.; Pliva, Inc.; Pliva USA, Inc.; Schwarz Pharma, Inc.; Teva Pharmaceuticals USA, Inc.; and Wyeth) opposed centralization, as did one Plaintiff from Vermont. [read post]
15 Dec 2016, 11:44 am
(Paul Buckowski / Times Union) Heritage Pharmaceuticals, Aurobindo Pharma USA, Citron Pharma, Mayne Pharma, Mylan Pharmaceuticals and Teva Pharmaceuticals USA are being targeted by the lawsuit. [read post]
21 Oct 2014, 12:00 am
The author is occasional and much-appreciated guest contributor Suleman Ali (Holly IP), who writes as follows:Teva UK Limited & Teva Pharmaceuticals Limited v Leo Pharma A/S & Leo Laboratories Limited[2014] EWHC 3096 (Pat) is a decision by Mr Justice Birss in the Patents Court, England and Wales. [read post]
29 Feb 2008, 1:50 am
Teva Pharmaceuticals USA, Inc., No. 04-940-JJF (D.Del. [read post]
1 Dec 2021, 6:22 am
The main defendants at issue in the Elmiron litigation include Janssen Pharmaceuticals (a subsidiary of Johnson & Johnson Pharmaceuticals, Inc.), Teva Branded Pharmaceutical Products R&D, Inc., and Teva Pharmaceuticals USA, Inc. [read post]
1 Dec 2021, 6:22 am
The main defendants at issue in the Elmiron litigation include Janssen Pharmaceuticals (a subsidiary of Johnson & Johnson Pharmaceuticals, Inc.), Teva Branded Pharmaceutical Products R&D, Inc., and Teva Pharmaceuticals USA, Inc. [read post]
1 Dec 2021, 6:22 am
The main defendants at issue in the Elmiron litigation include Janssen Pharmaceuticals (a subsidiary of Johnson & Johnson Pharmaceuticals, Inc.), Teva Branded Pharmaceutical Products R&D, Inc., and Teva Pharmaceuticals USA, Inc. [read post]
11 Nov 2009, 4:02 am
: Bilski (IP Frontline) US: Next up: Ariad v Lilly rehearing en banc (Patent Docs) Products Ablify (Aripiprazole) - US: Otsuka files patent infringement suit against Teva in response to Para IV challenge (Patent Docs) Boniva (Ibandronic acid) - US: Roche drops two lawsuits in response to Teva cancelling plans to manufacture generic Boniva (The IP Factor) Copaxone (Glatiramer) - US: Teva files amended complaint against Momenta/Sandoz to include infringement of three… [read post]
11 Nov 2009, 4:02 am
: Bilski (IP Frontline) US: Next up: Ariad v Lilly rehearing en banc (Patent Docs) Products Ablify (Aripiprazole) - US: Otsuka files patent infringement suit against Teva in response to Para IV challenge (Patent Docs) Boniva (Ibandronic acid) - US: Roche drops two lawsuits in response to Teva cancelling plans to manufacture generic Boniva (The IP Factor) Copaxone (Glatiramer) - US: Teva files amended complaint against Momenta/Sandoz to include infringement of three… [read post]
26 Sep 2009, 1:57 pm
Teva Pharmaceuticals and Sandoz (CAFC 2008-1480, -1481) precedential Inequitable conduct is not easily shown. [read post]
15 Apr 2007, 9:46 pm
" After the Federal Circuit decided Teva v. [read post]
16 Aug 2021, 6:32 am
” Furthermore, drugmakers AbbVie, Teva, and Endo are also missing from the settlement even though they “have been accused of misleadingly marketing their pain medicines as safe. [read post]
4 Sep 2009, 12:11 pm
Teva Pharms. [read post]
28 Nov 2008, 12:49 pm
You can separately subscribe to the Pharma & Biotech edition of the IP Think Tank Global week in Review by subscribing by email, or selecting ‘all posts’ or ‘Pharma, Biotech & Chem’ for the RSS option at the Subscribe page: [duncanbucknell.com] Highlights this week included: EPO Enlarged Board of Appeal turns down Wisconsin Alumni Research Foundation (WARF) stem cell application (IAM) (IPKat) (EPO) European Commission releases… [read post]
